INSURANCE – Amends existing law to revise provisions regarding 340B drug pricing program reporting.

This bill requires healthcare organizations participating in the federal 340B drug pricing program to submit annual reports to Idaho state agencies about their program participation and financial details. The reports must include information on drug acquisition costs, payments to contract pharmacies, savings generated, and how those savings are used for charity care or community benefits, broken down by insurance payer type. The data will be kept confidential and shared through a secure portal, with an aggregated summary made available publicly on the state website. The attorney general may use the information to investigate potential Medicaid fraud and ensure compliance with federal requirements.